TrustBank Takes $706,000 Position in Stryker Corporation $SYK

TrustBank acquired a new stake in shares of Stryker Corporation (NYSE:SYK) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,009 shares of the medical technology company’s stock, valued at approximately $706,000.

Several other hedge funds have also recently made changes to their positions in SYK. United Financial Planning Group LLC purchased a new position in shares of Stryker during the third quarter valued at approximately $27,000. CGC Financial Services LLC purchased a new position in shares of Stryker during the fourth quarter valued at approximately $29,000. Strive Asset Management LLC bought a new stake in Stryker during the third quarter valued at approximately $30,000. ANTIPODES PARTNERS Ltd bought a new stake in Stryker during the third quarter valued at approximately $34,000. Finally, Copia Wealth Management grew its position in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after buying an additional 69 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. BTIG Research cut their target price on shares of Stryker from $397.00 to $379.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Citigroup cut their target price on shares of Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research report on Tuesday, April 7th. Evercore set a $355.00 target price on shares of Stryker in a research report on Friday, May 1st. Piper Sandler restated an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $361.00 target price on shares of Stryker in a research report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Stryker presently has an average rating of “Moderate Buy” and a consensus price target of $395.48.

Insider Buying and Selling at Stryker

In other Stryker news, VP M Kathryn Fink sold 5,220 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.85, for a total value of $1,481,697.00. Following the completion of the transaction, the vice president directly owned 13,137 shares in the company, valued at $3,728,937.45. This represents a 28.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is currently owned by insiders.

Stryker Stock Performance

SYK opened at $313.08 on Wednesday. The firm has a market cap of $120.02 billion, a P/E ratio of 36.24, a PEG ratio of 1.99 and a beta of 0.80. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87. The company has a 50 day simple moving average of $324.33 and a two-hundred day simple moving average of $349.12. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The firm had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is presently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.